PharmaEssentia Corporation (6446.TW)

TWD 572.0

(-1.38%)

Long Term Debt Summary of PharmaEssentia Corporation

  • PharmaEssentia Corporation's latest annual long term debt in 2023 was 954.99 Million TWD , up 96.9% from previous year.
  • PharmaEssentia Corporation's latest quarterly long term debt in 2024 Q2 was 861.3 Million TWD , down -5.21% from previous quarter.
  • PharmaEssentia Corporation reported annual long term debt of 485.02 Million TWD in 2022, up 13.96% from previous year.
  • PharmaEssentia Corporation reported annual long term debt of 425.59 Million TWD in 2021, down -14.87% from previous year.
  • PharmaEssentia Corporation reported quarterly long term debt of 861.3 Million TWD for 2024 Q2, down -5.21% from previous quarter.
  • PharmaEssentia Corporation reported quarterly long term debt of 623.7 Million TWD for 2023 Q3, up 28.84% from previous quarter.

Annual Long Term Debt Chart of PharmaEssentia Corporation (2023 - 2019)

Historical Annual Long Term Debt of PharmaEssentia Corporation (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 954.99 Million TWD 96.9%
2022 485.02 Million TWD 13.96%
2021 425.59 Million TWD -14.87%
2020 499.95 Million TWD 37.53%
2019 363.53 Million TWD 0.0%

Peer Long Term Debt Comparison of PharmaEssentia Corporation

Name Long Term Debt Long Term Debt Difference
Grape King Bio Ltd 136.36 Million TWD -600.351%
Standard Chem & Pharm CO., LTD. 222.97 Million TWD -328.302%
Maywufa Company Ltd. 438.97 Million TWD -117.551%
ScinoPharm Taiwan, Ltd. 570.23 Million TWD -67.476%
Lotus Pharmaceutical Co., Ltd. 9.51 Billion TWD 89.968%
LIWANLI Innovation Co., Ltd. 361 Thousand TWD -264442.382%
YungShin Global Holding Corporation 241.99 Million TWD -294.634%
PhytoHealth Corporation 17.46 Million TWD -5369.633%
SCI Pharmtech, Inc. 845.52 Million TWD -12.947%
Formosa Laboratories, Inc. 2.03 Billion TWD 53.138%
Bora Pharmaceuticals Co., LTD. 3.48 Billion TWD 72.612%